|Year : 2019 | Volume
| Issue : 1 | Page : 17-22
Method for estimation of hippuric acid as a biomarker of toluene exposure in urine by high-performance liquid chromatography after extraction with ethyl acetate
Anupa Yadav, Anirban Basu, Amit Chakarbarti
Department of Industrial Hygiene, ICMR-Regional Occupational Health Centre (Eastern), Kolkata, West Bengal, India
|Date of Submission||06-Dec-2018|
|Date of Acceptance||27-Feb-2019|
|Date of Web Publication||9-Apr-2019|
Miss. Anupa Yadav
Department of Industrial Hygiene, ICMR-Regional Occupational Health Centre (Eastern), Block – DP, Sector – V, Salt Lake, Kolkata - 700 091, West Bengal
Source of Support: None, Conflict of Interest: None
Aim: This study aimed to establish liquid–liquid extraction (LLE) for estimation of hippuric acid (HA) in urine as a biomarker of the toluene exposure by high-performance liquid chromatography equipped with photodiode array detector (HPLC-PDAD).
Method: HA in urine was extracted by LLE and determined by HPLC-PDAD. The operating conditions with HPLC were ODS-2 hypersil column (250 mm × 4.6 mm, 5 μm), 0.1% trifluoro acetic acid (TFA) in acetonitrile and 0.1% TFA in water as mobile phase, 1 ml/min flow rate, and wavelength of 205 nm. The validity of the present method was tested by the estimation of HA in urine samples, collected from toluene-exposed (shoe workers) and unexposed or control subjects.
Results: Binary gradient system was used to achieve optimum separation. The analytical curve prepared for HA in aqueous solution in the range of 0.5–10 μg/ml showed determination coefficient value (R2) 0.998. Limit of detection and quantification (LOQ) were 0.46 and 1.53 μg/ml, respectively. The coefficients of variance for intraday precision were 1.4% for HA standard (5 μg/ml) and 1.1% for pooled urine, whereas inter-day precision values were 3.2% and 4.9% for HA standard and pooled urine, respectively. Method recovery obtained was 96%–120% for HA solutions containing 2, 3, and 5 μg/ml, demonstrating that precision and recovery of method were satisfactory. Compared to unexposed group, exposed group had significantly more HA. It was found significantly (P < 0.05) higher in urine of exposed workers (32.52 ± 10.91) than unexposed group (16.21 ± 10.14).
Conclusion: Sample preparation by LLE is simple and cost-effective for the determination of HA as a biomarker of toluene exposure by HPLC-PDAD. It can be used to detect HA in urine for population exposed to toluene.
Keywords: High-performance liquid chromatography, hippuric acid, liquid–liquid extraction, photodiode array detector, toluene exposure, urine
|How to cite this article:|
Yadav A, Basu A, Chakarbarti A. Method for estimation of hippuric acid as a biomarker of toluene exposure in urine by high-performance liquid chromatography after extraction with ethyl acetate. Environ Dis 2019;4:17-22
|How to cite this URL:|
Yadav A, Basu A, Chakarbarti A. Method for estimation of hippuric acid as a biomarker of toluene exposure in urine by high-performance liquid chromatography after extraction with ethyl acetate. Environ Dis [serial online] 2019 [cited 2022 Aug 20];4:17-22. Available from: http://www.environmentmed.org/text.asp?2019/4/1/17/255736
| Introduction|| |
Toluene is an aromatic hydrocarbon, also known as methylbenzene or phenylmethane. It is a clear and water-insoluble liquid with a sweet smell derived from benzene compound. Use of this chemical is quite extensive in paint industry, rubber, cosmetics, adhesive, and printing ink. Major sources of toluene in indoor environment are paint, thinner, together with tobacco smoke. There are three main routes of toluene exposure, namely inhalation, ingestion, and dermal contact. It is a highly volatile compound; therefore, inhalation is the most important exposure pathway to be considered. Moreover, once it enters into the human body, it gets deposited and accumulated very easily in the vital organs such as the brain, liver, kidneys, and other organs. Chronic exposure can cause health issues such as eye/skin irritation, dizziness, respiratory problems, impaired function of liver, kidney, and central nervous system (CNS).,
Once toluene is absorbed in the body via respiratory tract, then it is oxidized in liver microsomes mainly (68%) to hippuric acid (HA). HA is normally a main component of nonprotein nitrogen in urine. It is an important metabolic end product for protein or nucleic acid. It is also an established urinary biomarker in biological monitoring of people exposed to toluene., HA is excreted in urine with a half-life of 2–3 h. Metabolic process of toluene is given in [Figure 1].
Urinary HA has been extensively studied as an occupational biomarker for toluene exposure. This compound presents a good correlation with the degree of exposure and is one of the recommended biomarkers to assess exposure to toluene.,, Estimation of this biomarker in urine is one of the most useful ways for biomonitoring of occupational exposure to toluene. Studies reported that the lowest concentration of toluene in breathing environment is 30 ppm at which urinary HA increased to a measurable level., Various methods have been developed for the estimation of HA in urine such as colorimetric, spectrophotometric, and by high-performance liquid chromatography (HPLC).,,, However, all these methods are expensive and require a long sample preparation process. The objective of this work was to develop a simple and cost-effective technique for the measurement of HA in urine, using liquid–liquid extraction (LLE) and HPLC with ODS-2 Hypersil column and photodiode array detector.
| Materials and Methods|| |
HA (98%) as standard was procured from Merck, Germany. All the chemicals and solvents such as hydrochloric acid, sodium chloride, ethyl acetate, acetonitrile, trifluoroacetic acid, and water were of HPLC grade.
HPLC (Shimadzu, Japan) consisted of a system controller (Model: SLC-10 A, VP-Series), connected with an automated liquid sampler (Model: LC-10AT, VP series), spectrophotometer (Model: SPD-M 10A, Diode Array Detector), column oven, and a monitor. The column used was ODS-2 Hypersil, 250 mm, 4.6 mm, particle size 5 μm (Thermo).
The pump was operated at a flow rate of 1 ml/min; UV detection wavelength was set at 205 nm. The mobile phase used was 0.1% trifluoro acetic acid (TFA) in acetonitrile and 0.1% TFA in HPLC grade water with flow of 1 ml/min, sample injection volume was 20 μl, reverse phase analytical column ODS-2 Hypersil (250 mm, 4.6 mm, and 5 μm), and oven temperature 25°C was used for chromatographic system. Under these conditions, HA was eluted and detected in around 18.90 min.
Sample preparation procedure
Well-mixed urine sample (1 ml) was taken in centrifuge tube, added 80 μl of 6N HCL, 0.3 g sodium chloride, and 4 ml ethyl acetate. Then, all the contents of the centrifuge tube were mixed for 2 min by rotation and followed by centrifugation at 1100 rpm for 5 min. Then, 200 μl of the upper (organic) layer was transferred to HPLC vial and evaporated to dryness using a heated (30°C) water bath and a gentle stream of nitrogen. The dried residue was re-dissolved in 200 μl of distilled water. For analysis, 20 μl of it was injected into the HPLC.
Selectivity of the method was evaluated by comparing the analyte retention time (RT) and peak purity obtained for the standard solution and samples.
To obtain linearity, working standards containing HA in concentration range 0.5–10 μg/ml were prepared in aqueous solution and analyzed at optimized chromatographic conditions to obtain determination coefficient (R2) from calibration curve of analyte.
Limit of detection and quantification
Limit of detection (LOD) and limit of quantification (LOQ) for HA were determined based on standard deviation (σ) and slope (S) of calibration curve as per the guidelines of International Conference on Harmonization 2005 (LOD = 3 × σ/S; LOQ = 10 × σ/S).
Intraday and interday precision was measured using the coefficient of variation (CV) obtained for repetition of sample preparation to injection onto the chromatographic column. For intraday precision, samples were analyzed for three times within the same day, whereas for interday, test samples were analyzed for 3 consecutive days. Values of up to 20% were normally considered acceptable for analytical methods applied to environmental samples with complex matrices.,
Accuracy was determined using the percentage recovery of HA added to urine at concentrations 2, 3, and 5 μg/ml, with three replicates.
Accuracy (%) =100 × (Cspiked × Csample)/Cstd
where Cspiked denotes concentration of HA added to urine sample, Csample denotes concentration of HA in urine sample determined from calibration curve, and Cstd denotes concentration of HA standard.
Interference caused by the presence of the biological matrix was assessed by comparing the coefficient of determination obtained for analytical curve of HA prepared using aqueous solution and urine sample. The LLE was performed under the optimized conditions.
In order to validate the present method, biological monitoring was done in urine (five samples of each exposed and unexposed samples used for this work). Urine samples used for this method validation were collected under institutional intramural project, and the project was approved by the Institutional Ethics Committee. Postshift urine samples were collected from toluene-exposed workers and also collected from unexposed individuals used as control. The values of unexposed and exposed individuals were compared by Student's t-test, and P value was determined.
| Results|| |
Urinary HA is extensively used as an exposure biomarker of toluene as suggested by statutory bodies., In individuals exposed to toluene vapors such as workers of industries such as shoe making, painters, printing press, and cosmetics, HA in urine of exposed individuals can be found in higher concentrations than unexposed individuals. However, the expected amount of HA in exposed individuals may be 1.5 g/g creatinine as recommended by the American Conference on Hygiene of Governmental Industrial Hygienists. For this reason, it is advantageous to have a simple and easy method that allows the evaluation of this compound in the urine samples. Human urine is a complex matrix that contains proteins, hormones, salts, drugs, and a variety of other compounds. Therefore, to obtain maximum elution of HA from urine, the samples were extracted by LLE method and analyzed at optimized analytical conditions. Under these optimized chromatographic conditions, HA peak for standard solution and urine sample was detected in around 18.90 min at wavelength 205 nm as shown in [Figure 2]. Method selectivity was confirmed by comparing the RT of HA peak in the standard and sample chromatogram (A and B), under the same chromatographic conditions, and degree of purity of the eluted peak was determined using the LC solutions software, version 1.25 (Shimadzu, Japan). For peak purity, the evaluation was made from the absorption spectra at the RTs corresponding to the up slope, top, and down slope regions of the chromatographic peak, comparing them in order to identify any possibility of co-elution of other substance.
|Figure 2: Chromatograms obtained for the separation of hippuric acid at optimized chromatographic conditions. (a) Standard solution of hippuric acid (5 μg/ml); (b) Urine sample|
Click here to view
[Figure 3] presents the calibration curve with coefficient of determination (R2) value exceeding 0.9986 prepared using aqueous HA standards in the concentration range of 0.5–10 μg/ml. LOD and LOQ of the method were calculated using standard deviation (σ) and slope (S) of calibration curve, as described previously. The values obtained were 0.46 μg/ml (LOD) and 1.53 μg/ml (LOQ). In [Table 1], CV was calculated in order to determine the precision of the method. For intraday study, HA standards and urine sample were analyzed in three replicates, and inter-day study was performed in the same way for 3 consecutive days. The highest values of CV obtained were 1.4% and 8.1% for intra- and inter-day experiments, respectively, demonstrating that the method provided good precision. The results also showed that the precision was independent of the concentration of HA in sample. The accuracy of the method was determined using the recovery of HA standards 2, 3, and 5 μg/ml added to the urine. The concentration of HA in unfortified urine was 16 μg/ml, calculated from analytical curve prepared using aqueous standards. Accuracy obtained was 96%–120% as shown in [Table 2].
|Figure 3: Calibration curve of hippuric acid with concentration range 0.5–10 μg/ml|
Click here to view
|Table 1: Intra-day and Inter-day precision studies for determination of hippuric acid by high-performance liquid chromatography|
Click here to view
As the method is developed for biological fluids like urine, it is important to evaluate the matrix effect. In our results, the presence of matrix effect was found as shown in [Figure 4]. Slope of analytical curve prepared in urine was slightly higher than the analytical curve prepared in aqueous solution. Quantification of results was done with analytical curve prepared in urine to nullify the matrix effect. Displacement of analytical curve for urine and of aqueous solution was due to the presence of HA in urine, which has also been observed in other studies.,, The present method is validated by evaluating urinary HA concentration, in urine of exposed (shoe workers) and controls. When analytical results of exposed (n = 5) and unexposed (n = 5) groups were compared, it was found that exposed individuals had significantly more HA [Table 3], statistically these results were significant (P < 0.05), suggesting higher level of toluene exposure among workers.
|Figure 4: Analytical curve of hippuric acid prepared in aqueous solution (blue dots) and in urine (red squares)|
Click here to view
|Table 3: Results of hippuric acid biomonitoring among exposed individuals and controls|
Click here to view
| Discussion|| |
Workers engaged in shoe making, printing/painting work, cosmetic shops/saloons, petrochemical work, etc., have exposure to toluene., Chronic exposure to this volatile solvent can cause various health issues such as impaired function of liver, kidney, and CNS., Air monitoring of toluene is very time consuming, costly, and laborious. Therefore, it becomes necessary to develop a simple, easy, and cost-effective method for biomonitoring of this solvent. Urinary HA is recommended as an exposure biomarker for toluene. Estimation of urinary HA, with the present method, is simple. This method has multiple advantages, and one of them is that it has excellent linearity in the working range, precise LOD and LOQ, with adequate accuracy and precision. For spiked urine sample (5 μg HA/ml), recovery value was found higher, possibly because HA was already present in urine (16 μg/ml) in higher quantities. Ideally, the recovery study should be done with urine containing lower levels of analyte. In case of analytic methods involving complex matrix like urine, recovery values in the range 80%–120% are acceptable.,,
The second advantage of the method is that urine used for exposure monitoring can be easily obtained and is noninvasive, unlike blood samples. Sample preparation is easy and cost effective than other methods described in the literature. Although the present method is good enough to use, ethyl acetate is used as an extraction solvent, it may cause irritation to eye, skin, and respiratory tract if its vapors are inhaled by laboratory workers. To check the validity of method, urine samples of exposed and unexposed groups were analyzed, and it was found that exposed individuals had significantly more HA. These results were statistically significant (P < 0.05), suggesting higher level of toluene exposure among workers. Our findings were similar to as reported by Duydu et al. (1999). Therefore, this method can be used in any laboratory having HPLC and can be used for routine bio-monitoring of toluene-exposed workers.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Serap AA, Pembe O, Yusuf K, Huseyin K, Suheyla E. Medicolegal aspects of blood-urine toluene and urinary ortho-cresol concentration in toluene exposure. J Med Sci 2001;31:415-9.
ATSDR. Toxicological Profile for Toluene. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service; 2000.
U.S Environmental Protection Agency. Toxicological Review of Toluene, in Support of Summary Information on the Integrated Risk Information System (IRIS). Washington, D.C.: U.S Environmental Protection Agency; 2005.
Löf A, Hansen SH, Näslund P, Steiner E, Wallén M, Hjelm EW, et al.
Relationship between uptake and elimination of toluene and debrisoquin hydroxylation polymorphism. Clin Pharmacol Ther 1990;47:412-7.
Zuppi C, Rossetti DV, Vitali A, Vincenzoni F, Giardina B, Castagnola M, et al.
Determination of urinary hippuric acid by micellar electrokinetic capillary chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 2003;793:223-8.
International Programme on Chemical Safety (IPCS). Chemical. Environmental Health Criteria 52: Toluene. Geneva: World Health Organization; 1986.
Anderson CE, Loomis GA. Recognition and prevention of inhalant abuse. Am Fam Physician 2003;68:869-74.
Agency for Toxic Substances and Disease Registry; Division of Toxicology and Human Health Sciences Environmental Toxicology Branch; Atlanta, Georgia. 2017. Available from: https://www.atsdr.cdc.gov/toxprofiles/tp56.pdf
. [Last accessed on 2018 Sep 5].
Thiesen FV, Noto AR, Barros HM. Laboratory diagnosis of toluene-based inhalants abuse. Clin Toxicol (Phila) 2007;45:557-62.
American Conference of Governmental Industrial Hygienists. Threshold Limit Values for Chemicals Substances and Physical Agents, Biological Exposure Indices. Cincinnati, Ohio, USA: American Conference of Governmental Industrial Hygienists; 2009.
De Rosa E, Brugnone F, Bartolucci GB, Perbellini L, Bellomo ML, Gori GP, et al.
The validity of urinary metabolites as indicators of low exposures to toluene. Int Arch Occup Environ Health 1985;56:135-45.
Bahrami A, Jonidi-Jafari A, Folladi B, Mahjub H. Comparison of urinary o-Cresol and hippuric acid in drivers, gasoline station works and painters exposed to toluene in West of Iran. Pak J Biol Sci 2005;8:1001-5.
Kawai T, Mizunuma K, Okada Y, Horiguchi S, Ikeda M. Toluene itself as the best urinary marker of toluene exposure. Int Arch Occup Environ Health 1996;68:289-97.
Yoshida M, Akane A, Mitani T, Watabiki T. Simple colorimetric semiquantitation method of hippuric acid in urine for demonstration of toluene abuse. Leg Med (Tokyo) 2005;7:198-200.
Yacob AR, Zinalibdin MR. Spectrophotometry semiquantitation method hippuric acid in urine for demonstration of glue abuser. Indian J Forensic Med Toxicol 2010;4:22-32.
Yacob AR, Zinalibdin MR. High performance liquid chromatography determination of urinary hippuric acid and benzoic acid as indices for glue sniffer urine. World Acad Sci Technol 2010;38:973-8.
Lee CE, Lee J, Lee J, Eom HY, Kim MK, Suh JH, et al
. Rapid HPLC method for the simultaneous determination of eight urinary metabolites of toluene, xylene and styrene. B Korean Chem Soc 2009;30:2021-6.
Kiyoshi K, Yukio H, Keiko K, Takashi I. Determination of benzoic acid and hippuric acid in human plasma and urine by high performance liquid chromatography. J Chromatogr 1988;425:67-75.
Ogata M, Taguchi T. Quantitative analysis of urinary conjugates by HPLC: Excretion of hippuric acid and methylhippuric acids in the urine of subjects exposed to vapors of toluene and xylenes. Int Arch Occup Environ Health 1986;58:121-9.
International Conference on Harmonization (ICH) of Technical Requirements for the Registration of Pharmaceuticals for Human use, Validation of Analytical Procedures: Text and Methodology Q2 (R1) (1996); 2005.
Ribani M, Bottoli CB, Collins CH, Jardim IC, Melo LF. Validation for chromatographic and electrophoretic methods. Quimica Nova 2004;27:771-80.
Hasegawa K, Shiojima S, Koizumi A, Ikeda M. Hippuric acid and o-cresol in the urine of workers exposed to toluene. Int Arch Occup Environ Health 1983;52:197-208.
Andersson R, Carlsson A, Nordqvist MB, Sollenberg J. Urinary excretion of hippuric acid and o-cresol after laboratory exposure of humans to toluene. Int Arch Occup Environ Health 1983;53:101-8.
Martins I, Siqueira ME. Determination of trans, trans-muconic acid in urine: Validation of a high performance liquid chromatographic method. Braz J Pharm Sci 2002;38:205-13.
Rafaela PG, Ananda LS, Fabiana AL, Robson J, Cassia FA, Mauricio XC. Method for the determination of benzene metabolite t, t-muconic acid in urine by HPLC-UV with an Ion exclusion column. Separations 2016;3:14.
Duydu Y, Suzen S, Vural N, Erdem N, Uysal H. A modified method for determination of hippuric acid inurine by HPLC. Pharm Ankara 1999;28:37-46.
[Figure 1], [Figure 2], [Figure 3], [Figure 4]
[Table 1], [Table 2], [Table 3]